# Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects

> **NCT07323680** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Rhoshan Pharmaceuticals Inc** · enrollment: 40 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 325 mg Oral Aspirin
- **DRUG:** 325 mg aspirin by rapid IV push

## Key facts

- **NCT ID:** NCT07323680
- **Lead sponsor:** Rhoshan Pharmaceuticals Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-06-15
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07323680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07323680, "Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07323680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*